The influence of anti-parasitic therapy on the course of the glomerulopathy associated with Schistosomiasis mansoni.
Although several aspects of the association between S. mansoni infection and renal disease are well known, the influence of the anti-parasitic therapy on the clinical course of the glomerulopathy remains undefined. With the aim of studying this aspect, 16 patients with glomerulopathy associated with schistosomiasis mansoni were evaluated (proteinuria and levels of BUN and creatinine) before therapy, 1 week, 1 month, 2-3 months and 6 months after therapy of the parasitic infections. During the follow-up of such cases no benefit could unquestionably be demonstrated in the patients. Also, no permanent deterioration of renal function related to anti-parasitic therapy could be documented. It is concluded that the treatment of the S. mansoni infection, once the consequent glomerulopathy is clinically apparent, does not influence the clinical course of the disease.
D006801:Humans; D006826:Hycanthone / Q000627:therapeutic use; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000209:etiology*; D010073:Oxamniquine / Q000627:therapeutic use; D012555:Schistosomiasis mansoni / Q000150:complications / Q000188:drug therapy*; D012556:Schistosomicides / Q000627:therapeutic use*
D012556:Schistosomicides; D010073:Oxamniquine; D006826:Hycanthone